We are live on
!
Find out more
CCM
Chiron Capital Management Portfolio holdings
AUM
$111M
This Fund
S&P 500
This Quarter
Est. Return
+5.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$118M
AUM Growth
-$3.62M
(-3%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-8.83%
Top 10 Holdings %
Top 10 Hldgs %
65.92%
Holding
89
New
11
Increased
23
Reduced
32
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.23M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.29M |
| 3 |
Becton Dickinson
BDX
|
+$1.05M |
| 4 |
Merck
MRK
|
+$1.01M |
| 5 |
SPDR Gold Trust
GLD
|
+$908K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$6.7M |
| 2 |
Intel
INTC
|
+$2.86M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.9M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$1.11M |
| 5 |
CHL
China Mobile Limited
CHL
|
+$967K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.35% |
| 2 | Energy | 6.3% |
| 3 | Consumer Staples | 5.84% |
| 4 | Technology | 4.56% |
| 5 | Financials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$127B
| $48.3M | 40.99% |
765,053
-7,414
| -1% | -$461K |
|
2
Gilead Sciences
GILD
$161B
| $8M | 6.79% |
123,795
-3,060
| -2% | -$197K |
|
|
3
Pfizer
PFE
$140B
| $5.57M | 4.73% |
153,829
+90,843
| +144% | +$3.23M |
|
4
CVS Health
CVS
$137B
| $2.89M | 2.45% |
38,370
-780
| -2% | -$56.8K |
|
|
5
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $2.45M | 2.08% |
99,984
-82,196
| -45% | -$1.9M |
|
6
Kraft Heinz
KHC
$30.4B
| $2.25M | 1.91% |
56,237
-3,185
| -5% | -$115K |
|
7
First Trust Enhanced Short Maturity ETF
FTSM
$6.51B
| $2.2M | 1.86% |
36,640
+5,330
| +17% | +$320K |
|
|
8
Intel
INTC
$466B
| $2.18M | 1.85% |
34,114
-47,912
| -58% | -$2.86M |
|
9
AB InBev
BUD
$158B
| $2.15M | 1.82% |
34,170
+9,279
| +37% | +$599K |
|
10
AT&T
T
$165B
| $1.68M | 1.43% |
73,630
+10,377
| +16% | +$229K |
|
11
Home Depot
HD
$332B
| $1.67M | 1.42% |
5,485
-1,500
| -21% | -$413K |
|
|
12
Merck
MRK
$324B
| $1.67M | 1.41% |
22,637
+13,722
| +154% | +$1.01M |
|
13
ExxonMobil
XOM
$651B
| $1.66M | 1.41% |
29,808
-13,374
| -31% | -$701K |
|
14
First Trust Managed Municipal ETF
FMB
$2.03B
| $1.53M | 1.3% |
27,080
+2,680
| +11% | +$152K |
|
15
Amazon
AMZN
$2.5T
| $1.44M | 1.22% |
9,320
-300
| -3% | -$47.6K |
|
16
SLB Ltd
SLB
$77.8B
| $1.39M | 1.18% |
51,000
+1,039
| +2% | +$27.4K |
|
17
Enterprise Products Partners
EPD
$83.8B
| $1.22M | 1.03% |
55,286
-3,436
| -6% | -$75.5K |
|
18
Apple
AAPL
$4.89T
| $1.21M | 1.02% |
9,862
-729
| -7% | -$93.6K |
|
19
Aflac
AFL
$63.9B
| $1.19M | 1.01% |
23,187
-2,398
| -9% | -$115K |
|
20
Raymond James Financial
RJF
$32.5B
| $1.16M | 0.99% |
14,250
-600
| -4% | -$44.7K |
|
|
SPLK
21
DELISTED
Splunk Inc
SPLK
| $1.12M | 0.95% |
+8,250
| New | +$1.29M |
|
22
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.32B
| $1.09M | 0.93% |
21,360
+4,360
| +26% | +$224K |
|
23
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
| $1.05M | 0.89% |
19,860
+5,160
| +35% | +$278K |
|
24
BP
BP
$113B
| $1.04M | 0.89% |
42,850
-911
| -2% | -$21.9K |
|
|
25
Becton Dickinson
BDX
$43.1B
| $1.02M | 0.87% |
+4,305
| New | +$1.05M |
|
Similar funds
VPW
EGP
FA
LP
WWMP
HCM
FCU
OCA
Chiron Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Chiron Capital Management held 89 positions worth $118M, down 3% from $121M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Chiron Capital Management withdrew a net $10.4M in Q1 2021, closing 17 positions and reducing 32 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $6.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 52% a quarter earlier, followed by Energy and Consumer Staples.
Against the trend, Chiron Capital Management opened a new position in Splunk Inc worth $1.12M.
- Chiron Capital Management's largest Q1 2021 buy was Splunk Inc: 8,250 shares worth $1.12M.
- Chiron Capital Management added most to Pfizer in Q1 2021, an estimated $3.23M increase.
- Chiron Capital Management's biggest Q1 2021 reduction was Intel, cutting an estimated $2.86M.
- Chiron Capital Management fully exited State Street Financial Select Sector SPDR ETF in Q1 2021, selling an estimated $6.7M.
- Chiron Capital Management's ten largest holdings make up 66% of its $118M portfolio in Q1 2021.
- Chiron Capital Management opened 11 new positions and closed 17 in Q1 2021.
- Chiron Capital Management's portfolio value fell 3% quarter-over-quarter to $118M.
Based on Chiron Capital Management's 13F filing for Q1 2021, filed 18 May 2021.